Drug: NORVIR Injury: Hyperbilirubinaemia Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 102146435 | NORVIR | Hyperbilirubinaemia | JANSSEN | 53.28 YR | M | 0 | 20160810 | JP |
| 119143502 | NORVIR | Hyperbilirubinaemia | BRISTOL MYERS SQUIBB | 0.00 DY | F | 1 KG | 20160825 | US |
| 119162782 | NORVIR | Hyperbilirubinaemia | BRISTOL MYERS SQUIBB | 0.00 DY | F | 1 KG | 20160825 | US |
| 124432062 | NORVIR | Hyperbilirubinaemia | GLAXOSMITHKLINE | 48.03 YR | F | 0 | 20160705 | IT |
| 124716132 | NORVIR | Hyperbilirubinaemia | VIIV | 48.03 YR | F | 0 | 20160705 | IT |
| 125270431 | NORVIR | Hyperbilirubinaemia | GLAXOSMITHKLINE | 49.64 YR | M | 0 | 20160705 | IT |
| 125272631 | NORVIR | Hyperbilirubinaemia | VIIV | 49.64 YR | M | 0 | 20160705 | IT |
| 760997718 | NORVIR | Hyperbilirubinaemia | JANSSEN | 49.37 YR | M | 0 | 20160914 | JP |
Total Records: 8 Number of Pages: 1